Cancer Research, Statistics, and Treatment最新文献

筛选
英文 中文
Translation and validation of the Hindi, Marathi, and Bangla versions of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire: Anal Cancer (QLQ-ANL27) module: A prospective cohort study 欧洲癌症研究和治疗组织生活质量问卷印地语、马拉地语和孟加拉语版本的翻译和验证:肛门癌(QLQ-ANL27)模块:前瞻性队列研究
Cancer Research, Statistics, and Treatment Pub Date : 2024-02-01 DOI: 10.4103/crst.crst_217_23
R. Krishnatry, Revathy Krishnamurthy, Purva Pawar, Devankshi Rane, Debanjan Chakraborty, Debanjali Datta, Sayan Das, Utpal Gaikwad, Aasma Siddiqui, Suman Ghosh, Akanksha Anup, Tejaswi Ambre, Shivkumar Gudi, Reena Engineer
{"title":"Translation and validation of the Hindi, Marathi, and Bangla versions of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire: Anal Cancer (QLQ-ANL27) module: A prospective cohort study","authors":"R. Krishnatry, Revathy Krishnamurthy, Purva Pawar, Devankshi Rane, Debanjan Chakraborty, Debanjali Datta, Sayan Das, Utpal Gaikwad, Aasma Siddiqui, Suman Ghosh, Akanksha Anup, Tejaswi Ambre, Shivkumar Gudi, Reena Engineer","doi":"10.4103/crst.crst_217_23","DOIUrl":"https://doi.org/10.4103/crst.crst_217_23","url":null,"abstract":"\u0000 \u0000 \u0000 The European Organization for the Research and Treatment of Cancer (EORTC) has developed a commonly used validated questionnaire specific to anal cancer (EORTC QLQ-ANL27). It is used as an adjunct to the core EORTC quality-of-life (QoL) questionnaire QLQ-C30. This validated questionnaire was not available in any Indian language, and therefore, Indian patients not familiar with English could not fill it.\u0000 \u0000 \u0000 \u0000 We aimed to translate and validate the EORTC QLQ-ANL27 module in Hindi, Marathi, and Bangla languages.\u0000 \u0000 \u0000 \u0000 This study was conducted in the Department of Radiation Oncology at the Tata Memorial Hospital, a tertiary cancer center in Mumbai, India, from September 01, 2022, to March 31, 2023. The QLQ-ANL27 questionnaire was translated into Hindi, Marathi, and Bangla languages using the standard EORTC guidelines. The overall process comprised two independent forward translations of the original English questionnaire into the target languages, followed by reconciliation between the two forward translations. The reconciled version was then back translated to English. The report generated was sent to the EORTC translation unit (TU) for review. Once approved by the EORTC TU, these translated versions were pilot tested on 30 patients (10 for each language) with cancer of the rectum or anal canal. After responding to the questionnaires, each patient was individually interviewed to explore any difficulty encountered while answering the QoL questionnaire. The interviewer specifically asked whether the patients found any words or sentences difficult to answer, confusing, or upsetting, and for suggestions on better phrasing.\u0000 \u0000 \u0000 \u0000 The EORTC QLQ-ANL27 was translated to Hindi, Marathi, and Bangla, followed by back translation into English within a period of 2 months between September 2022 and October 2022. The translated versions were approved by the EORTC TU in October 2022. Validation of the translated versions was conducted between December 2022 and March 2023 in 30 patients diagnosed with anorectal cancer. The median age of the patients was 55 (interquartile range, 29–77); the male-to-female ratio was 2:1. There were no suggestions or doubts in the Hindi, Marathi, and Bangla questionnaires during the pilot testing. After reviewing the pilot testing reports, the EORTC TU approved the translated versions of QLQ-ANL27. The reliability of the translated questionnaires was confirmed using Cronbach’s alpha, which were 0.838, 0.743, and 0.808 for the Hindi, Marathi, and Bangla versions, respectively.\u0000 \u0000 \u0000 \u0000 The Hindi, Marathi, and Bangla translations of the QLQ-ANL27 module have been validated and approved by the EORTC and are now available for use (Clinical Trials Registry-India, CTRI/2022/12/047970).\u0000","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"35 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139814796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation and validation of the Hindi, Marathi, and Bangla versions of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire: Anal Cancer (QLQ-ANL27) module: A prospective cohort study 欧洲癌症研究和治疗组织生活质量问卷印地语、马拉地语和孟加拉语版本的翻译和验证:肛门癌(QLQ-ANL27)模块:前瞻性队列研究
Cancer Research, Statistics, and Treatment Pub Date : 2024-02-01 DOI: 10.4103/crst.crst_217_23
R. Krishnatry, Revathy Krishnamurthy, Purva Pawar, Devankshi Rane, Debanjan Chakraborty, Debanjali Datta, Sayan Das, Utpal Gaikwad, Aasma Siddiqui, Suman Ghosh, Akanksha Anup, Tejaswi Ambre, Shivkumar Gudi, Reena Engineer
{"title":"Translation and validation of the Hindi, Marathi, and Bangla versions of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire: Anal Cancer (QLQ-ANL27) module: A prospective cohort study","authors":"R. Krishnatry, Revathy Krishnamurthy, Purva Pawar, Devankshi Rane, Debanjan Chakraborty, Debanjali Datta, Sayan Das, Utpal Gaikwad, Aasma Siddiqui, Suman Ghosh, Akanksha Anup, Tejaswi Ambre, Shivkumar Gudi, Reena Engineer","doi":"10.4103/crst.crst_217_23","DOIUrl":"https://doi.org/10.4103/crst.crst_217_23","url":null,"abstract":"\u0000 \u0000 \u0000 The European Organization for the Research and Treatment of Cancer (EORTC) has developed a commonly used validated questionnaire specific to anal cancer (EORTC QLQ-ANL27). It is used as an adjunct to the core EORTC quality-of-life (QoL) questionnaire QLQ-C30. This validated questionnaire was not available in any Indian language, and therefore, Indian patients not familiar with English could not fill it.\u0000 \u0000 \u0000 \u0000 We aimed to translate and validate the EORTC QLQ-ANL27 module in Hindi, Marathi, and Bangla languages.\u0000 \u0000 \u0000 \u0000 This study was conducted in the Department of Radiation Oncology at the Tata Memorial Hospital, a tertiary cancer center in Mumbai, India, from September 01, 2022, to March 31, 2023. The QLQ-ANL27 questionnaire was translated into Hindi, Marathi, and Bangla languages using the standard EORTC guidelines. The overall process comprised two independent forward translations of the original English questionnaire into the target languages, followed by reconciliation between the two forward translations. The reconciled version was then back translated to English. The report generated was sent to the EORTC translation unit (TU) for review. Once approved by the EORTC TU, these translated versions were pilot tested on 30 patients (10 for each language) with cancer of the rectum or anal canal. After responding to the questionnaires, each patient was individually interviewed to explore any difficulty encountered while answering the QoL questionnaire. The interviewer specifically asked whether the patients found any words or sentences difficult to answer, confusing, or upsetting, and for suggestions on better phrasing.\u0000 \u0000 \u0000 \u0000 The EORTC QLQ-ANL27 was translated to Hindi, Marathi, and Bangla, followed by back translation into English within a period of 2 months between September 2022 and October 2022. The translated versions were approved by the EORTC TU in October 2022. Validation of the translated versions was conducted between December 2022 and March 2023 in 30 patients diagnosed with anorectal cancer. The median age of the patients was 55 (interquartile range, 29–77); the male-to-female ratio was 2:1. There were no suggestions or doubts in the Hindi, Marathi, and Bangla questionnaires during the pilot testing. After reviewing the pilot testing reports, the EORTC TU approved the translated versions of QLQ-ANL27. The reliability of the translated questionnaires was confirmed using Cronbach’s alpha, which were 0.838, 0.743, and 0.808 for the Hindi, Marathi, and Bangla versions, respectively.\u0000 \u0000 \u0000 \u0000 The Hindi, Marathi, and Bangla translations of the QLQ-ANL27 module have been validated and approved by the EORTC and are now available for use (Clinical Trials Registry-India, CTRI/2022/12/047970).\u0000","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"41 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139874501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathological complete response in breast cancer: Is it truly a surrogate for outcome? 乳腺癌的病理完全缓解:它真的是预后的替代品吗?
Cancer Research, Statistics, and Treatment Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_201_23
J. Ghosh, S. Ganguly
{"title":"Pathological complete response in breast cancer: Is it truly a surrogate for outcome?","authors":"J. Ghosh, S. Ganguly","doi":"10.4103/crst.crst_201_23","DOIUrl":"https://doi.org/10.4103/crst.crst_201_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"32 1","pages":"232 - 234"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81668083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Sabse bada kaun - Me or “C”? "我"还是" C " ?
Cancer Research, Statistics, and Treatment Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_28_23
Vandana N. Mahajan
{"title":"Sabse bada kaun - Me or “C”?","authors":"Vandana N. Mahajan","doi":"10.4103/crst.crst_28_23","DOIUrl":"https://doi.org/10.4103/crst.crst_28_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"19 1","pages":"285 - 285"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82248514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous expulsion of a huge hemorrhagic cervical leiomyoma: A rare case report 巨大出血性宫颈平滑肌瘤自发性排出一例
Cancer Research, Statistics, and Treatment Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_138_23
P. Balakrishnan, V. Sharmila
{"title":"Spontaneous expulsion of a huge hemorrhagic cervical leiomyoma: A rare case report","authors":"P. Balakrishnan, V. Sharmila","doi":"10.4103/crst.crst_138_23","DOIUrl":"https://doi.org/10.4103/crst.crst_138_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"31 1","pages":"357 - 359"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89946185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' reply to Sathe et al., Cherulil et al., Vaishya et al., and Gupta et al. 作者对Sathe等人、Cherulil等人、Vaishya等人和Gupta等人的答复。
Cancer Research, Statistics, and Treatment Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_177_23
Purvish M. Parikh, V. Talwar, Monu Goyal
{"title":"Authors' reply to Sathe et al., Cherulil et al., Vaishya et al., and Gupta et al.","authors":"Purvish M. Parikh, V. Talwar, Monu Goyal","doi":"10.4103/crst.crst_177_23","DOIUrl":"https://doi.org/10.4103/crst.crst_177_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"1 1","pages":"338 - 340"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78329846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular diseases in testicular germ cell tumors survivors 睾丸生殖细胞肿瘤幸存者的心血管疾病
Cancer Research, Statistics, and Treatment Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_31_23
A. Alizadehasl, M. Mohseni, Ronak Ahmadi
{"title":"Cardiovascular diseases in testicular germ cell tumors survivors","authors":"A. Alizadehasl, M. Mohseni, Ronak Ahmadi","doi":"10.4103/crst.crst_31_23","DOIUrl":"https://doi.org/10.4103/crst.crst_31_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"16 1","pages":"352 - 353"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78454334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving outcomes for colorectal cancer in India: Time to take the first step! 改善印度结直肠癌的治疗效果:是时候迈出第一步了!
Cancer Research, Statistics, and Treatment Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_174_23
P. Patil
{"title":"Improving outcomes for colorectal cancer in India: Time to take the first step!","authors":"P. Patil","doi":"10.4103/crst.crst_174_23","DOIUrl":"https://doi.org/10.4103/crst.crst_174_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"22 1","pages":"328 - 329"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82143383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Narrative review on genetic counseling for hereditary cancers: General considerations 遗传性癌症遗传咨询的综述:一般考虑
Cancer Research, Statistics, and Treatment Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_16_23
Ehsan Ulhaq, Febin Huda, C. Suhail, H. Sheth, R. Anu
{"title":"Narrative review on genetic counseling for hereditary cancers: General considerations","authors":"Ehsan Ulhaq, Febin Huda, C. Suhail, H. Sheth, R. Anu","doi":"10.4103/crst.crst_16_23","DOIUrl":"https://doi.org/10.4103/crst.crst_16_23","url":null,"abstract":"The field of oncology has made great strides in the last decade. There have been tremendous advancements in precision oncology and cutting-edge diagnostics to match the unprecedented rise in the incidence of cancer globally. Hereditary cancer syndromes which account for between 5-10% of the total cancer burden, occupy a novel niche, offering the opportunity to receive an early diagnosis through targeted surveillance, adopt preventive screening measures, and preemptively control the disease. To prepare this review, we searched in PubMed, international government web pages, and the National Comprehensive Cancer Network guidelines for published literature on genetic testing in hereditary cancers. This review article represents a consensus between the authors, based on the literature review, with a view to being relevant in the Indian setting. Genetic counseling plays a pivotal role in the diagnosis and management of hereditary cancers. India must adopt a streamlined approach to the treatment of hereditary cancers by enhancing awareness and incorporating the right protocols for genetic counseling. This educational series, focused on genetic counseling for hereditary and sporadic cancers, is the first step in generating awareness among individuals and clinicians in India.","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"30 1","pages":"239 - 247"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82659738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Authors' reply to Patel and Lucke-Wold 作者对Patel和lucke - world的回复
Cancer Research, Statistics, and Treatment Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_183_23
Mehdi Mahmoodkhani, Mehdi Shafiei, M. Sharifi, A. Naeimi, D. Tehrani
{"title":"Authors' reply to Patel and Lucke-Wold","authors":"Mehdi Mahmoodkhani, Mehdi Shafiei, M. Sharifi, A. Naeimi, D. Tehrani","doi":"10.4103/crst.crst_183_23","DOIUrl":"https://doi.org/10.4103/crst.crst_183_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"23 1","pages":"332 - 333"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88496982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信